Notably, although it has been reported that knockdown of ACTL6A inhibits HPV E6/E7 oncogene expression and restores the p53-related signaling pathway in cervical cancer cells (26), its biological roles in cervical cancer remain largely unknown. The gene discussed is TP53; the disease is cervical cancer.